Guideline on the design and conduct of cystic fibrosis clinical trials: The European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN)

Journal of Cystic Fibrosis

Volumn 10, Issue SUPPL. 2, 2011, Pages

  De Boeck, K ^a   Bulteel, V ^a   Tiddens, H ^b   Wagner, T ^c   Fajac, I ^d   Conway, S ^e   Dufour, F ^f   Smyth, A R ^g   Lee, T ^e   Sermet, I ^d   Kassai, B ^h   Elborn, S ⁱ  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c GOETHE UNIVERSITY   (Germany)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^f Vaincre la Mucoviscidose   (France)

^g UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^h HOSPICES CIVILS DE LYON   (France)

ⁱ BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

Clinical trials; Cystic fibrosis; Research network

Indexed keywords

ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); COOPERATION; CYSTIC FIBROSIS; DRUG INDUSTRY; EUROPE; GOOD CLINICAL PRACTICE; HUMAN; INTERPERSONAL COMMUNICATION; PATIENT INFORMATION; PATIENT PARTICIPATION; PRODUCTIVITY; PROFESSIONAL STANDARD; QUESTIONNAIRE; RESPONSIBILITY; TELECONFERENCE;

CLINICAL TRIALS AS TOPIC; COOPERATIVE BEHAVIOR; CYSTIC FIBROSIS; EUROPE; HUMANS; SOCIETIES, MEDICAL;

EID: 79958158650     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/S1569-1993(11)60010-6     Document Type: Article

References (30)

1. Buzzetti R, Salvatore D, Baldo E, et al. An overview of international literature from cystic fibrosis registries: 1. Mortality and survival studies in cystic fibrosis. J Cyst Fibros 2009, 8(4):229-237.
2. Corey M, Edwards L, Levison H, Knowles M Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis. J Pediatr 1997, 131(6):809-814.
3. Briggs TA, Bryant M, Smyth RL Controlled clinical trials in cystic fibrosis - are we doing better?. J Cyst Fibros 2006, 5(1):3-8.
4. Döring G, Elborn JS, Johannesson M, et al. Clinical trials in cystic fibrosis. J Cyst Fibros 2007, 6(2):85-99.
5. Zielenski J Genotype and phenotype in cystic fibrosis. Respiration 2000, 67(2):117-133.
6. Decaestecker K, Decaestecker E, Castellani C, Jaspers M, Cuppens H, De Boeck K Genotype/phenotype correlation of the G85E mutation in a large cohort of cystic fibrosis patients. Eur Respir J 2004, 23(5):679-684.
7. Marshall C Clinical practice guidelines for the care of infants identified through cystic fibrosis newborn screening. J Pediatr 2009, 155(Suppl. 4):S71-116.
8. Linnane BM, Hall GL, Nolan G, et al. Lung function in infants with cystic fibrosis diagnosed by newborn screening. Am J Respir Crit Care Med 2008, 178(12):1238-1244.
9. Claire Wainwright: plenary session 3 of the North American CF conference, Minneapolis, USA, Oct. 15-17 2009 (). http://www.nacfconference.org/plenaryarchive.asp.
10. Lebecque P, Leonard A, De Boeck K, et al. Early referral to cystic fibrosis specialist centre impacts on respiratory outcome. J Cyst Fibros 2009, 8(1):26-30.
11. Kerem E, Conway S, Elborn S, Heijerman H Standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibros 2005, 4(1):7-26.
12. Elborn JS, Hodson M, Bertram C Implementation of European standards of care for cystic fibrosis - provision of care. J Cyst Fibros 2009, 8(5):348-355.
13. Binns R, Driscoll B New European rules on orphan drugs. Pharm Sci Technolo Today 2000, 3(7):218-219.
14. Organization, review, and administration of cooperative studies (Greenberg Report): a report from the Heart Special Project Committee to the National Advisory Heart Council, May 1967. Control Clin Trials 1988, 9(2):137-148.
15. Goss CH, Mayer-Hamblett N, Kronmal RA, Ramsey BW The cystic fibrosis therapeutics development network (CF TDN): a paradigm of a clinical trials network for genetic and orphan diseases. Adv Drug Deliv Rev 2002, 54(11):1505-1528.
16. Standaert TA, Boitano L, Emerson J, et al. Standardized procedure for measurement of nasal potential difference: an outcome measure in multicenter cystic fibrosis clinical trials. Pediatr Pulmonol 2004, 37(5):385-392.
17. Corey M Power considerations for studies of lung function in cystic fibrosis. Proc Am Thorac Soc 2007, 4(4):334-337.
18. Goss CH, Mayer-Hamblett N, Kronmal RA, Williams J, Ramsey BW Laboratory parameter profiles among patients with cystic fibrosis. J Cyst Fibros 2007, 6(2):117-123.
19. Francis S. Collins: plenary session 1 of the North American CF conference, Minneapolis, USA, Oct. 15-17 2009 (). http://www.nacfconference/org/plenaryarchive.asp.
20. Hoiby N, Frederiksen B, Pressler T Eradication of early Pseudomonas aeruginosa infection. J Cyst Fibros 2005, 4(Suppl 2):49-54.
21. Hoiby N Diffuse panbronchiolitis and cystic fibrosis: East meets West. Thorax 1994, 49(6):531-532.
22. Jaffe A, Francis J, Rosenthal M, Bush A Long-term azithromycin may improve lung function in children with cystic fibrosis. Lancet 1998, 351(9100):420.
23. Equi A, Balfour-Lynn IM, Bush A, Rosenthal M Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial. Lancet 2002, 360(9338):978-984.
24. Colombo C, Setchell KD, Podda M, et al. Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis. J Pediatr 1990, 117(3):482-489.
25. Strandvik B, Gronowitz E, Enlund F, Martinsson T, Wahlstrom J Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis. J Pediatr 2001, 139(5):650-655.
26. Touw DJ, Brimicombe RW, Hodson ME, Heijerman HG, Bakker W Inhalation of antibiotics in cystic fibrosis. Eur Respir J 1995, 8(9):1594-1604.
27. Mehta G, Macek M, Mehta A European Registry Working Group. Cystic fibrosis across Europe: EuroCareCF analysis of demographic data from 35 countries. J Cyst Fibros 2010, 9(Suppl 2):S5-21.
28. Smyth A, Barbato A, Beydon N, et al. Respiratory medicines for children: current evidence, unlicensed use and research priorities. Eur Respir J 2010, 35(2):247-265.
29. Pinxten W, Dierickx K, Nys H Diversified harmony: Supranational and domestic regulation of pediatric clinical trials in the European Union. J Cyst Fibros 2011, 10(Suppl 2):183-198.
30. Pinxten W, Dierickx K, Nys H Ethical principles and legal requirements for pediatric research in the EU: an analysis of the European normative and legal framework surrounding pediatric clinical trials. Eur J Pediatr 2009, 168(10):1225-1234.